Clinical

This channel newsfeed includes clinical content on treating patients or the clinical implications in a variety of cardiac subspecialties and disease states. The channel includes news on cardiac surgery, interventional cardiology, heart failure, electrophysiology, hypertension, structural heart disease, use of pharmaceuticals, and COVID-19.

Hospital pays out $4.2M to settle lawsuit involving ‘violent and uncontrollable’ patient
A psychiatric patient suffering from hallucinations injured employees at University of Iowa Health Care during a physical altercation. Clinicians restrained and sedated him successfully, but the cocktail of drugs allegedly caused his heart to stop, leading to a permanent brain injury. The case has been settled out of court.
Doctors still unsure about Trump’s heart health after ‘weird’ memo
It is still unclear which imaging exams President Donald Trump underwent to evaluate his cardiovascular health. The White House shared a memo Monday as an attempt to put this topic to bed—but questions remain.
AI has already transformed TAVR care—and the best is yet to come
Advanced AI technologies are starting to play a bigger role in TAVR care, helping cardiologists plan ahead, make critical decisions and predict potential complications. Looking to the future, though, it is clear this is just the beginning.
Siemens Healthineers unveils new AI-powered CCTA software
The new software, announced at RSNA 2025 in Chicago, was built to evaluate CCTA images for signs of coronary artery disease and improve cath lab efficiency.
Waiting is no longer ‘good medicine’: Data shows treating severe AS with TAVR before symptoms appear improves outcomes, reduces costs
TAVR is increasingly seen as the preferred option for symptomatic severe aortic stenosis, and clinical guidelines in the U.S. reserve their highest recommendations for patients who experience symptoms. Asymptomatic patients, meanwhile, are typically managed by clinical surveillance or a “watch and wait” approach; no symptoms means no treatment.

Sotagliflozin the first drug of its kind to limit heart attacks, strokes in high-risk patients

Sotagliflozin, a dual SGLTI and SGLT2 inhibitor, can significantly reduce the risk of adverse cardiovascular events in patients with type 2 diabetes, CKD and additional cardiovascular risk factors, according to a new study of more than 10,000 patients.

White matter hyperintensities might not be a marker of TBI after all

New findings are calling into question the notion that white matter hyperintensities are biomarkers of brain injuries.

CABG coronary artery bypass grafting heart surgery

CABG still the ‘gold standard’ for revascularization in patients with 3-vessel CAD and CKD

The median follow-up period was more than nine years, allowing researchers to compare long-term outcomes after both CABG and PCI.

Osteoporosis drug shows potential to treat heart disease

Researchers used advanced AI to see if any FDA-approved medications could potentially reverse one of the mutations behind dilated cardiomyopathy. Risedronate, a popular osteoporosis medication, is the one candidate that got the job done.

Biosense Webster, part of Johnson & Johnson MedTech, shared updated data on its Varipulse pulsed field ablation (PFA) system at AF Symposium 2024 in Boston,

Johnson & Johnson resumes PFA rollout after stopping to review safety concerns

Johnson & Johnson MedTech has resumed the U.S. rollout of its Varipulse PFA system, sharing new warnings to help physicians.

Veterans with heart disease often receive better care through VA than they would elsewhere

Military veterans face an increased risk of cardiovascular disease, making it especially important to ensure they receive high-quality care.

Opportunistic imaging detects signs of heart disease in lung cancer patients

These findings show that opportunistic imaging could go a long way toward making more patients aware of the cardiovascular risks they face—all without requiring additional scans to be performed.

AI artificial intelligence stethoscope doctor

LAAO or DOAC? Mayo Clinic AI helps guide treatment of AFib patients

It can be challenging to know which AFib patients are the best candidates for LAAO. A new algorithm out of Mayo Clinic aims to address that problem.

Clinical

Hospital pays out $4.2M to settle lawsuit involving ‘violent and uncontrollable’ patient

Doctors still unsure about Trump’s heart health after ‘weird’ memo

AI has already transformed TAVR care—and the best is yet to come

Siemens Healthineers unveils new AI-powered CCTA software

Waiting is no longer ‘good medicine’: Data shows treating severe AS with TAVR before symptoms appear improves outcomes, reduces costs